Статья

COVID-19 in solid organ transplant recipients: Initial report from national multicenter observational study «rokkor-recipient» [ОСОБеННОСти КлиНичеСКОГО течеНиЯ КОрОНАВирУСНОЙ иНФеКЦии cOvid-19 У реЦиПиеНтОВ СердЦА, ПОчКи, ПечеНи: ПерВые реЗУлЬтАты НАЦиОНАлЬНОГО МНОГОЦеНтрОВОГО НАБлЮдАтелЬНОГО иССледОВАНиЯ «рОККОр-реЦиПиеНт»]

S. Gautier, A. Shevchenko, O. Tsirulnikova, S. Khomyakov, O. Kotenko, V. Vinogradov, I. Abyzov, G. Avetisyan, A. Anisimov, L. Artyukhina, M. Bekov, V. Berdinsky, V. Bogdanov, A. Bykov, A. Vinokurov, A. Goncharova, D. Evdokimov, D. Ezersky, V. Zagainov, V. Zakharevich, K. Zelenin, E. Ivanova, A. Kartashev, N. Kvadratova, I. Kim, N. Koloskova, V. Korobka, I. Kurbanuglov, M. Lysenko, I. Miloserdov, Y. Moisyuk, G. Nikolaev, I. Ostrovskaya, N. Petrova, A. Petryaev, A. Pinchuk, V. Platonov, V. Poptsov, Z. Porchkhidze, D. Saydulaev, A. Sapozhnikov, S. Semchenko, M. Skorobogatov, V. Tereshchenko, N. Frolova, D. Khalikova, T. Khalilulin,
2021

We herein present our initial report from «ROKKOR-recipient», a national multicenter observational study. The prevalence, risk factors, clinical manifestations and outcomes of the novel coronavirus disease 2019 (COVID-19) in solid organ transplant recipients receiving immunosuppressive therapy were investigated. The study enrolled 251 COVID-19 patients (220 kidney recipients, 7 liver recipients, 1 liver-kidney recipient, and 23 heart recipients). The subjects came from 20 regions in Russia. The symptoms, clinical presentation, imaging and lab test results, therapy and outcomes of COVID-19 were described. It was established that solid organ transplant recipients with COVID-19 have a higher risk of developing adverse events. Predictors of adverse events include associated cardiovascular diseases, pulmonary diseases, diabetes, and kidney failure. Symptoms of the disease include dyspnea, rash and catarrhal signs, as well as initial low blood oxygen saturation (SpO2 <92%), leukocytosis (white blood cell count >10 × 109/L), elevated creatinine levels (>130 μmol/L) and a marked decrease in glomerular filtration rate, requiring hemodialysis. Performing organ transplant surgery in COVID-19 does not increase the risk of adverse events but could save the lives of waitlisted terminally ill patients. © 2020 Russian Transplant Society. All rights reserved.

Цитирование

Похожие публикации

Документы

Источник

Версии

  • 1. Version of Record от 2021-04-27

Метаданные

Об авторах
  • S. Gautier
    Shumakov National Medical Research Center of Transplantology and Artificial Organs, Moscow, Russian Federation
  • A. Shevchenko
    Sechenov University, Moscow, Russian Federation
  • O. Tsirulnikova
    Pirogov Medical University, Moscow, Russian Federation
  • S. Khomyakov
    Moscow City Scientific and Practical Center for Nephrology and Transplant Kidney Pathology, City Clinial Hospital No. 52, Moscow, Russian Federation
  • O. Kotenko
    Research Institute of Health Care Organization and Medical Management, Moscow, Russian Federation
  • V. Vinogradov
    Republican Clinical Hospital, Cheboksary, Russian Federation
  • I. Abyzov
    Clinical Hospital No. 1, Smolensk, Russian Federation
  • G. Avetisyan
    City Clinical Hospital No. 7, Kazan, Russian Federation
  • A. Anisimov
    State Novosibirsk Regional Clinical Hospital, Novosibirsk, Russian Federation
  • L. Artyukhina
    Leningrad Regional Clinical Hospital, St. Petersburg, Russian Federation
  • M. Bekov
    Regional Clinical Hospital, Krasnoyarsk, Russian Federation
  • V. Berdinsky
    Sergeev Regional Clinical Hospital No. 1, Khabarovsk, Russian Federation
  • V. Bogdanov
    Volga Regional Medical Center, Nizhny Novgorod, Russian Federation
  • A. Bykov
    Ministry of Health of the Arkhangelsk Oblast, Arkhangelsk, Russian Federation
  • A. Vinokurov
    Rostov Regional Clinical Hospital, Rostov-on-Don, Russian Federation
  • A. Goncharova
    Vladimirsky Moscow Regional Research Clinical Institute, Moscow, Russian Federation
  • D. Evdokimov
    Almazov National Medical Research Centre, St. Petersburg, Russian Federation
  • D. Ezersky
    Saratov Regional Clinical Hospital, Saratov, Russian Federation
  • V. Zagainov
    Tula Regional Clinical Hospital, Tula, Russian Federation
  • V. Zakharevich
    Sklifosovsky Research Institute of Emergency Care, Moscow, Russian Federation
  • K. Zelenin
    District Clinical Hospital, Khanty-Mansiysk, Russian Federation
  • E. Ivanova
    Shumakov National Medical Research Center of Transplantology and Artificial Organs in the city of Volzhsky, Volzhsky, Russian Federation
  • A. Kartashev
    Center for Organ and Tissue Transplantation, Regional Clinical Hospital No. 1, Tyumen, Russian Federation
  • N. Kvadratova
    Kabanov City Clinical Hospital No. 1, Omsk, Russian Federation
  • I. Kim
  • N. Koloskova
  • V. Korobka
  • I. Kurbanuglov
  • M. Lysenko
  • I. Miloserdov
  • Y. Moisyuk
  • G. Nikolaev
  • I. Ostrovskaya
  • N. Petrova
  • A. Petryaev
  • A. Pinchuk
  • V. Platonov
  • V. Poptsov
  • Z. Porchkhidze
  • D. Saydulaev
  • A. Sapozhnikov
  • S. Semchenko
  • M. Skorobogatov
  • V. Tereshchenko
  • N. Frolova
  • D. Khalikova
  • T. Khalilulin
Название журнала
  • Vestnik Transplantologii i Iskusstvennykh Organov
Том
  • 22
Выпуск
  • 3
Страницы
  • 8-17
Ключевые слова
  • creatinine; adult; Article; blood cell count; cardiovascular disease; coronavirus disease 2019; diabetes mellitus; dyspnea; female; glomerulus filtration rate; graft recipient; heart graft; human; kidney failure; kidney graft; laboratory test; liver graft; lung disease; major clinical study; male; multicenter study; observational study; organ transplantation; outcome assessment; prevalence; rash; risk factor
Издатель
  • Russian Transplant Society
Тип документа
  • journal article
Тип лицензии Creative Commons
  • CC
Правовой статус документа
  • Свободная лицензия
Источник
  • scopus